You are here
Iovance Biotherapeutics to Present at Two Investor Conferences in June
SAN CARLOS, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that company management will present at two investor conferences in June:
- Jefferies 2018 Global Healthcare Conference in New York, NY on Thursday, June 7, 2018 at 9:00 a.m. ET
- JMP Securities Life Sciences Conference in New York, NY on Wednesday, June 20, 2018 at 1:00 p.m. ET
A live audio webcast of both presentations will be available by visiting the Investors section of Iovance Biotherapeutics' website at http://ir.iovance.com/. A replay of the webcasts will be archived on Iovance Biotherapeutics’ website for 30 days following the presentations.